Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04856059Not ApplicableRecruiting

Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI

Role: collaborator

NCT01640769Not ApplicableCompleted

Imaging Study of Allocation of Pacing Targets in Cardiac Resynchronization Therapy

Role: lead

NCT04065802Not ApplicableUnknown

Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia Management

Role: collaborator

NCT01608893Not ApplicableUnknown

Carvedilol for Prevention of Paroxysmal Atrial Fibrillation

Role: collaborator

NCT01307735Unknown

International Myocarditis Registry

Role: lead

All 5 trials loaded